Aurobindo Pharma board considers merger of subsidiaries

Industry:    2 days ago

Approves the filing of scheme of merger of Auro Vaccines with Curateq Biologics

The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger of Auro Vaccines, a wholly owned step-down subsidiary of the Company with Curateq Biologics, a wholly owned subsidiary of the Company, with Hon’ble NCLT, Hyderabad.

print
Source: